(IN BRIEF) Researchers at the University of Copenhagen and their collaborators found that adults with type 2 diabetes who do not consistently take their prescribed glucose-lowering medication have a higher rate of cardiovascular disease. The study followed 79,510 adults newly … Read the full press release →
Posted in Denmark, Education, Healthcare, Pharma & Biotech, Science
Tagged Andreas Bartholdy, blood sugar control, blood vessels, cardiovascular disease, cardiovascular risk before age 55, CBMR, chronic disease management, clinical decision making, comorbidities, Danish national health registries, Danish Registry Study Highlights Importance of Staying on Diabetes Medication, Denmark, diabetes medication, diabetes treatment support, glucose-lowering therapy, heart attacks, heart health, Ischemic heart disease, Jordi Merino, Lise B Nielsen, long-term adherence, lower income, Majken K Jensen, major cardiovascular events, Marta Guasch-Ferré, medication adherence, nationwide cohort study, non-insulin medication, Novo Nordisk Foundation, Novo Nordisk Foundation Center for Basic Metabolic Research, observational study, patients living alone, personalised patient support, pharmacy records, prescription records, public health, Simon Rasmussen, socioeconomic factors, strokes, The Lancet Regional Health Europe, Tri-Long Nguyen, type 2 diabetes, Type 2 Diabetes Patients With Low Medication Adherence Face Higher Heart Disease Risk, University of Copenhagen, younger adults, Younger Type 2 Diabetes Patients Face Higher Cardiovascular Risk When Treatment Adherence Drops
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
